Dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: A case report

Saved in:
Bibliographic Details
Published inDermatologic therapy Vol. 35; no. 8; pp. e15623 - n/a
Main Authors Pop, Samantha R., Strock, Daniel, Smith, Robert J.
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.08.2022
Subjects
bullous drug eruption
bullous pemphigoid
dupilumab
immune‐related adverse events
immunotherapy
pembrolizumab
pembrolizumab
bullous drug eruption
Bullous pemphigoid
immune-related adverse events
immunotherapy
dupilumab
Online AccessGet full text

Cover

More Information
ISSN:1396-0296
1529-8019
DOI:10.1111/dth.15623